ReutersReuters

Rhythm's experimental drug to treat a form of obesity meets main goal in study

Refinitiv閱讀少於1分鐘

Rhythm Pharmaceuticals RYTM said on Wednesday that its experimental drug to treat a type of obesity met the main goal in a mid-stage study.

登入或建立一個永久免費帳戶來閱讀此新聞